机译:Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease
Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, 20 Staniford;
Department of Surgery, Ophthalmology Service, Walter Reed Army Medical Center, Washington, DC;
Department of Ophthalmology and Visual Science, University of British Columbia, Vancouver, BCDepartment of Ophthalmology and Visual Science, Dalhousie University, Halifax, NS, CanadaDepartment of Ophthalmology, Medical Retina Unit and Ocular Angiogenesis Group, University of;